Standard Chemical & Pharmaceutical Co., Ltd.
Research Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) on Bullrun: market cap TWD 11.38B, P/E 11.6, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1720.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 11.38B
- P/E11.6
- Dividend yield3.6%
- Financial periodQ2 2026
- RevenueTWD 1.87B
- Net incomeTWD 258.60M
- Free cash flowTWD 99.11M
- Gross margin43.9%
Valuation Snapshot
latest market cap is TWD 11.38B; P/E is 11.6; dividend yield is 3.6%.
Peer valuation comparison
Latest P/E is 11.63x versus a Healthcare sector median of 21.8x (46.7% below).
Latest dividend yield is 3.62% versus a Healthcare sector median of 2.4% (50.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 11.38B | 11.6 | 3.5% | 2 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2 TWD, yield 3.6%.
About Standard Chemical & Pharmaceutical Co., Ltd.
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications;
ETFs that hold Standard Chemical & Pharmaceutical Co., Ltd.
US-listed ETFs
Standard Chemical & Pharmaceutical Co., Ltd. is held by 9 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | <0.01% | 0.43% |
| Avantis Emerging Markets Ex-China Equity ETF (AVXC) | 0.01% | 0.33% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.02% | 0.65% |
| Dimensional Emerging Markets Sustainability Core 1 ETF (DFSE) | <0.01% | 0.41% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Standard Chemical & Pharmaceutical Co., Ltd.'s market cap?
Standard Chemical & Pharmaceutical Co., Ltd.'s market capitalization is TWD 11.38B.
What is Standard Chemical & Pharmaceutical Co., Ltd.'s P/E ratio?
Standard Chemical & Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 11.6.
Does Standard Chemical & Pharmaceutical Co., Ltd. pay a dividend?
Standard Chemical & Pharmaceutical Co., Ltd. has a dividend yield of 3.6%.
What does Standard Chemical & Pharmaceutical Co., Ltd. do?
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products.